Merck's Keytruda Doubled PFS In Some Colorectal Cancer Patients In ASCO Late-Breaker

 
• By Jessica Merrill
  
Three green arrows hitting the center of a black target and 3 darts out of the objective. Business strategy or competitive advantage concept. Space for text on the left side.
Merck's Keytruda doubled PFS in some colorectal cancer patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences